Nicholas F. Banfield
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Nicholas F. Banfield has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Brian P. Cunningham
TRIA Orthopedic Center, Bloomington, MN, USA
5 shared publications - Haley D. Puckett
TRIA Orthopedic Center, Bloomington, MN, USA
4 shared publications - Kehinde S. Agoro
Department of Orthopaedic Surgery, TRIA Orthopedic Center, Bloomington, Minnesota
3 shared publications - Rebekah M. Kleinsmith
TRIA Orthopedic Center, Bloomington, MN, USA
3 shared publications - Rylan A. Behnke
Twin Cities Orthopedics, Edina, Minnesota, USA
2 shared publications - Adam Hadro
Department of Orthopaedic Surgery, Park Nicollet Methodist Hospital, St. Louis Park, MN, USA
1 shared publication
Latest Publications
- Open Access
- 4 September 2026
- Published by Elsevier in JSES Reviews, Reports, and Techniques
- Vol. 7 (1)
Time-driven activity-based costing comparison of intramedullary nails versus locking plates for proximal humerus fractures: what is the primary cost driver?
- 4 September 2026
- Published by Elsevier in JSES Reviews, Reports, and Techniques
- Vol. 7 (1)
Open AccessTime-driven activity-based costing comparison of intramedullary nails versus locking plates for proximal humerus fractures: what is the primary cost driver?
- 24 April 2026
- Published by Elsevier in Journal of Shoulder and Elbow Surgery
- Vol. 35 (10) , 2542-2547
Cost analysis of different fixation techniques for distal biceps ruptures using time-driven activity-based costing
- 24 April 2026
- Published by Elsevier in Journal of Shoulder and Elbow Surgery
- Vol. 35 (10) , 2542-2547
Cost analysis of different fixation techniques for distal biceps ruptures using time-driven activity-based costing
- 19 June 2025
- Published by Wolters Kluwer Health in Journal of Bone and Joint Surgery
- Vol. 107 (15) , 1680-1689
Measurement of Value in Uncomplicated Total Knee Arthroplasty
Background: Patient-level value analysis (PLVA) has been applied to several orthopaedic procedures but has not yet been utilized to assess the value of total knee arthroplasty (TKA). The purpose of this study was to evaluate the 1-year episode of care for TKA with use of PLVA to identify characteristics that influence value at both the patient and surgeon level. Methods: The institutional patient-reported outcome (PRO) database was queried for all patients who underwent TKA from 2020 to 2022. Patients were excluded on the basis of an index revision procedure, a pathology other than primary osteoarthritis, unicompartmental knee arthroplasty, robotic-assisted TKA, incomplete baseline or 1-year PROs, concomitant procedures (i.e., bilateral TKA or hardware removal), complications requiring readmission or reoperation, TKA without patellar resurfacing, the use of constrained implants, incomplete cost information, or other hip or knee arthroplasty procedure during the 1-year episode of care. PROs of interest included preoperative and 1-year postoperative Knee injury and Osteoarthritis Outcome Score-Joint Replacement (KOOS-JR) scores. Episode-of-care costs were calculated using time-driven activity-based costing. The 1-year value quotient (V KOOS ) was calculated for each patient as the ratio of the 1-year change in KOOS-JR score to the total episode-of-care cost. Results: A total of 684 patients (62% female; mean age, 68 ± 8 years) met the inclusion criteria. The mean KOOS-JR score significantly increased from baseline (53 ± 11) to 1 year (79 ± 14; p < 0.001), with a mean improvement of 26 ± 16. The mean total episode-of-care cost was $9,563 ± $2,370. There was no significant correlation between episode-of-care costs and the change in KOOS-JR score (r = 0.02; p = 0.581). Surgery performed at an ambulatory surgery center (p < 0.001) and as an outpatient procedure (p = 0.036) were predictive of lower costs. Patient-specific instrumentation (p < 0.001) and a tibial stem extension (p < 0.001) were predictive of higher costs. Older age (p = 0.023) and male sex (p = 0.007) were predictive of less improvement in KOOS-JR scores from baseline to 1 year. Conclusions: Our study identified patient and surgical characteristics that drive costs and PROs in TKA. PLVA can be used to identify “bright spots” in orthopaedic procedures to optimize care delivery. Level of Evidence: Prognostic Level IV . See Instructions for Authors for a complete description of levels of evidence.
- 19 June 2025
- Published by Wolters Kluwer Health in Journal of Bone and Joint Surgery
- Vol. 107 (15) , 1680-1689
Measurement of Value in Uncomplicated Total Knee Arthroplasty
Background: Patient-level value analysis (PLVA) has been applied to several orthopaedic procedures but has not yet been utilized to assess the value of total knee arthroplasty (TKA). The purpose of this study was to evaluate the 1-year episode of care for TKA with use of PLVA to identify characteristics that influence value at both the patient and surgeon level. Methods: The institutional patient-reported outcome (PRO) database was queried for all patients who underwent TKA from 2020 to 2022. Patients were excluded on the basis of an index revision procedure, a pathology other than primary osteoarthritis, unicompartmental knee arthroplasty, robotic-assisted TKA, incomplete baseline or 1-year PROs, concomitant procedures (i.e., bilateral TKA or hardware removal), complications requiring readmission or reoperation, TKA without patellar resurfacing, the use of constrained implants, incomplete cost information, or other hip or knee arthroplasty procedure during the 1-year episode of care. PROs of interest included preoperative and 1-year postoperative Knee injury and Osteoarthritis Outcome Score-Joint Replacement (KOOS-JR) scores. Episode-of-care costs were calculated using time-driven activity-based costing. The 1-year value quotient (V KOOS ) was calculated for each patient as the ratio of the 1-year change in KOOS-JR score to the total episode-of-care cost. Results: A total of 684 patients (62% female; mean age, 68 ± 8 years) met the inclusion criteria. The mean KOOS-JR score significantly increased from baseline (53 ± 11) to 1 year (79 ± 14; p < 0.001), with a mean improvement of 26 ± 16. The mean total episode-of-care cost was $9,563 ± $2,370. There was no significant correlation between episode-of-care costs and the change in KOOS-JR score (r = 0.02; p = 0.581). Surgery performed at an ambulatory surgery center (p < 0.001) and as an outpatient procedure (p = 0.036) were predictive of lower costs. Patient-specific instrumentation (p < 0.001) and a tibial stem extension (p < 0.001) were predictive of higher costs. Older age (p = 0.023) and male sex (p = 0.007) were predictive of less improvement in KOOS-JR scores from baseline to 1 year. Conclusions: Our study identified patient and surgical characteristics that drive costs and PROs in TKA. PLVA can be used to identify “bright spots” in orthopaedic procedures to optimize care delivery. Level of Evidence: Prognostic Level IV . See Instructions for Authors for a complete description of levels of evidence.
- 19 May 2025
- Published by Elsevier in Journal of Orthopaedics
- Vol. 66, 173-178
Effect of postoperative NSAID use on opioid consumption after rotator cuff repair
- 19 May 2025
- Published by Elsevier in Journal of Orthopaedics
- Vol. 66, 173-178
Effect of postoperative NSAID use on opioid consumption after rotator cuff repair